Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
AMRN

AMRN - Amarin Corp PLC Stock Price, Fair Value and News

$15.03-0.66 (-4.21%)
Market Closed

6/100

AMRN

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

6/100

AMRN

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$13.01

Target 3M

$14.63

Target 6M

$13.82

AMRN Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

AMRN Price Action

Last 7 days

-1.7%

Last 30 days

7.0%

Last 90 days

-8.3%

Trailing 12 Months

27.4%

AMRN RSI Chart

AMRN Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

AMRN Valuation

Market Cap

6.3B

Price/Earnings (Trailing)

-72.54

Price/Sales (Trailing)

27.57

EV/EBITDA

-72.02

Price/Free Cashflow

-286

AMRN Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$13.01

Target 3M

$14.63

Target 6M

$13.82

AMRN Fundamentals

AMRN Revenue

Revenue (TTM)

226.7M

Rev. Growth (Yr)

17.43%

Rev. Growth (Qtr)

-31.72%

AMRN Earnings

Earnings (TTM)

-86.2M

Earnings Growth (Yr)

69.21%

Earnings Growth (Qtr)

45.27%

AMRN Profitability

EBT Margin

-37.53%

Return on Equity

-18.78%

Return on Assets

-13.06%

Free Cashflow Yield

-0.35%

AMRN Investor Care

Shares Dilution (1Y)

1.17%

Diluted EPS (TTM)

-4.01

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2025214.1M219.4M226.7M0
2024277.5M264.8M241.0M228.6M
2023360.5M346.3M322.4M306.9M
2022535.6M475.6M423.4M369.2M
2021601.2M620.4M605.9M583.2M
2020511.5M546.0M590.1M614.1M
2019258.6M306.7M363.8M429.8M
2018190.4M197.8M205.8M229.2M
2017139.2M151.3M165.9M181.1M
201691.4M106.8M118.0M130.1M
201559.2M64.3M71.6M81.8M
201435.0M42.1M47.8M54.2M
201300026.4M
Get all data in R, Python etc through our Historical Stock Data APIs

About Amarin Corp PLC

AMRN
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
 CEO
 WEBSITEamarincorp.com
 SECTORHealthcare
 INDUSTRYDrug Manufacturers General
 EMPLOYEES365

Amarin Corp PLC Frequently Asked Questions

AMRN is the stock ticker symbol of Amarin Corp PLC. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Amarin Corp PLC is 6.25 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check AMRN's fair value in chart for subscribers.

The fair value guage provides a quick view whether AMRN is over valued or under valued. Whether Amarin Corp PLC is cheap or expensive depends on the assumptions which impact Amarin Corp PLC's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for AMRN.

As of Wed Jan 28 2026, AMRN's PE ratio (Price to Earnings) is -72.54 and Price to Sales (PS) ratio is 27.57. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. AMRN PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Amarin Corp PLC has provided -0.058 (multiply by 100 for percentage) rate of return.